Real Time Touch

new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)

Real Time Touch

Civitas Therapeutics Inc patents

Recent patent applications related to Civitas Therapeutics Inc. Civitas Therapeutics Inc is listed as an Agent/Assignee. Note: Civitas Therapeutics Inc may have other listings under different names/spellings. We're not affiliated with Civitas Therapeutics Inc, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "C" | Civitas Therapeutics Inc-related inventors

Use of simple amino acids to form porous particles

Particles having a tap density of less than 0.4 g/cm3 include a hydrophobic amino acid or salt thereof and a therapeutic, prophylactic or diagnostic agent or any combination thereof. Preferred particles include a phospholipid, have a median geometric diameter between about 5 and about 30 microns and an aerodynamic diameter... Civitas Therapeutics Inc

Rapid relief of motor fluctuations in parkinson's disease

The present invention provides methods for treating OFF episodes in a Parkinson's Disease patient comprising administering levodopa to the pulmonary system of a patient wherein after administration, the patient's Unified Parkinson's Disease Rating Scale (UP-DRS) Part 3 score is improved by, for example, at least about 5 points as compared... Civitas Therapeutics Inc

Powder inhaler devices

An improved inhalation device is provided for facilitating inhalation by a patient of powder medicaments contained in a receptacle. The inhalation device includes a staple assembly comprising a plunger and staple that are securely and robustly coupled to one another. Embodiments of the inhalation device have a cap that prevents... Civitas Therapeutics Inc

Inhalable epinephrine

The present invention is directed toward particles for delivery of epinephrine to the respiratory system and methods for treating a patient in need of epinephrine. The particles and respirable compositions comprising the particles of the present invention described herein comprise the bioactive agent epinephrine, or a salt thereof, as a... Civitas Therapeutics Inc

Composition of a spray-dried powder for pulmonary delivery of a long acting neuraminidase inhibitor (lani)

The present invention is related to pharmaceutical formulations and methods of treating a subject afflicted with the influenza virus, the method includes administering to the respiratory tract of the patient particles that include more than about 5% to about 50% weight percent (wt %) of a neuraminidase inhibitor. The particles... Civitas Therapeutics Inc

Triptan powders for pulmonary delivery

The invention provides stable, spray-dried, particle formulations containing a triptan, preferably sumatriptan, or a pharmaceutically acceptable salt thereof, which are useful for pulmonary administration to the respiratory tract of a patient for the treatment of disease.... Civitas Therapeutics Inc

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009


This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. is not affiliated or associated with Civitas Therapeutics Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Civitas Therapeutics Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by